Accelerate Diagnostics Price to Book Ratio 2010-2024 | AXDX
Historical price to book ratio values for Accelerate Diagnostics (AXDX) over the last 10 years. The current price to book ratio for Accelerate Diagnostics as of January 10, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Accelerate Diagnostics Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-01-10 | 1.20 | 0.00 | |
| 2024-09-30 | 1.71 | $-1.95 | -0.88 |
| 2024-06-30 | 1.17 | $-1.47 | -0.79 |
| 2024-03-31 | 0.99 | $-1.18 | -0.84 |
| 2023-12-31 | 3.92 | $-1.37 | -2.87 |
| 2023-09-30 | 5.75 | $-2.42 | -2.38 |
| 2023-06-30 | 8.10 | $-2.69 | -3.01 |
| 2023-03-31 | 7.00 | $-3.89 | -1.80 |
| 2022-12-31 | 7.06 | $-2.28 | -3.09 |
| 2022-09-30 | 15.20 | $-1.03 | -14.80 |
| 2022-06-30 | 9.93 | $-7.77 | -1.28 |
| 2022-03-31 | 14.40 | $-8.16 | -1.77 |
| 2021-12-31 | 52.20 | $-5.18 | -10.07 |
| 2021-09-30 | 58.30 | $-6.12 | -9.52 |
| 2021-06-30 | 80.60 | $-11.34 | -7.11 |
| 2021-03-31 | 83.20 | $-11.14 | -7.47 |
| 2020-12-31 | 75.80 | $-10.90 | -6.95 |
| 2020-09-30 | 106.60 | $-8.71 | -12.24 |
| 2020-06-30 | 151.60 | $-6.58 | -23.05 |
| 2020-03-31 | 83.30 | $-4.17 | -19.97 |
| 2019-12-31 | 169.00 | $-1.35 | -125.30 |
| 2019-09-30 | 185.70 | $1.87 | 99.28 |
| 2019-06-30 | 228.80 | $4.77 | 47.96 |
| 2019-03-31 | 210.20 | $7.89 | 26.64 |
| 2018-12-31 | 115.00 | $10.58 | 10.87 |
| 2018-09-30 | 229.50 | $14.28 | 16.07 |
| 2018-06-30 | 223.00 | $17.54 | 12.71 |
| 2018-03-31 | 228.50 | $19.74 | 11.58 |
| 2017-12-31 | 262.00 | $21.32 | 12.29 |
| 2017-09-30 | 224.50 | $23.45 | 9.57 |
| 2017-06-30 | 273.50 | $25.69 | 10.65 |
| 2017-03-31 | 242.00 | $13.29 | 18.21 |
| 2016-12-31 | 207.50 | $15.11 | 13.74 |
| 2016-09-30 | 272.60 | $17.74 | 15.37 |
| 2016-06-30 | 143.90 | $20.51 | 7.02 |
| 2016-03-31 | 143.70 | $23.37 | 6.15 |
| 2015-12-31 | 214.90 | $25.98 | 8.27 |
| 2015-09-30 | 161.80 | $8.98 | 18.01 |
| 2015-06-30 | 258.10 | $11.04 | 23.38 |
| 2015-03-31 | 225.00 | $13.17 | 17.08 |
| 2014-12-31 | 191.90 | $14.78 | 12.98 |
| 2014-09-30 | 214.80 | $16.21 | 13.25 |
| 2014-06-30 | 260.00 | $17.65 | 14.73 |
| 2014-03-31 | 218.10 | $9.26 | 23.55 |
| 2013-12-31 | 122.00 | $9.97 | 12.24 |
| 2013-09-30 | 134.10 | $10.85 | 12.36 |
| 2013-06-30 | 81.20 | $7.09 | 11.46 |
| 2013-03-31 | 72.70 | $7.75 | 9.38 |
| 2012-12-31 | 40.30 | 0.00 | |
| 2012-10-31 | 36.00 | $5.31 | 6.79 |
| 2012-09-30 | 33.30 | 0.00 | |
| 2012-07-31 | 32.70 | 0.00 | |
| 2012-06-30 | 26.90 | 0.00 | |
| 2012-04-30 | 27.30 | $3.62 | 7.54 |
| 2012-03-31 | 10.50 | 0.00 | |
| 2012-01-31 | 12.80 | $4.04 | 3.17 |
| 2011-10-31 | 28.70 | $4.20 | 6.84 |
| 2011-07-31 | 38.90 | 0.00 | |
| 2011-04-30 | 38.60 | $4.50 | 8.58 |
| 2011-01-31 | 13.00 | $4.61 | 2.82 |
| 2010-10-31 | 11.00 | $4.63 | 2.37 |
| 2010-07-31 | 8.70 | 0.00 | |
| 2010-04-30 | 8.30 | $2.89 | 2.87 |
| 2010-01-31 | 6.80 | $3.05 | 2.23 |
| 2009-10-31 | 12.80 | $3.41 | 3.75 |
| 2009-07-31 | 27.00 | 0.00 | |
| 2009-04-30 | 19.80 | $3.89 | 5.08 |
| 2009-01-31 | 22.00 | $4.07 | 5.41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.032B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $199.883B | 24.39 |
| Intuitive Surgical (ISRG) | United States | $186.649B | 97.58 |
| Edwards Lifesciences (EW) | United States | $42.814B | 27.19 |
| Alcon (ALC) | Switzerland | $41.161B | 27.54 |
| IQVIA Holdings (IQV) | United States | $35.414B | 19.51 |
| IDEXX Laboratories (IDXX) | United States | $33.479B | 39.43 |
| DexCom (DXCM) | United States | $30.662B | 46.18 |
| Waters (WAT) | United States | $21.866B | 32.33 |
| STERIS (STE) | Ireland | $19.984B | 23.01 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.343B | 0.00 |
| Hologic (HOLX) | United States | $16.281B | 17.58 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.998B | 13.34 |
| Sysmex ADR (SSMXY) | Japan | $11.450B | 35.90 |
| Globus Medical (GMED) | United States | $11.143B | 28.22 |
| Penumbra (PEN) | United States | $9.211B | 90.22 |
| Masimo (MASI) | United States | $9.025B | 43.67 |
| Teleflex (TFX) | United States | $8.316B | 13.26 |
| Glaukos (GKOS) | United States | $8.253B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.433B | 25.13 |
| PROCEPT BioRobotics (PRCT) | United States | $4.340B | 0.00 |
| Veracyte (VCYT) | United States | $3.134B | 94.05 |
| Inari Medical (NARI) | United States | $3.033B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.533B | 14.62 |
| Tandem Diabetes Care (TNDM) | United States | $2.354B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.318B | 17.61 |
| TransMedics (TMDX) | United States | $2.232B | 70.75 |
| Elekta AB (EKTAY) | Sweden | $2.095B | 18.83 |
| Integra LifeSciences Holdings (IART) | United States | $1.776B | 9.28 |
| RxSight (RXST) | United States | $1.393B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.285B | 0.00 |
| Artivion (AORT) | United States | $1.177B | 78.00 |
| Pulse Biosciences (PLSE) | United States | $1.094B | 0.00 |
| OPKO Health (OPK) | United States | $0.990B | 0.00 |
| Paragon 28 (FNA) | United States | $0.897B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.728B | 12.37 |
| AxoGen (AXGN) | United States | $0.722B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.717B | 16.90 |
| IRadimed (IRMD) | United States | $0.696B | 37.63 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.660B | 0.00 |
| SiBone (SIBN) | United States | $0.584B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.554B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.506B | 26.63 |
| Pacific Biosciences Of California (PACB) | United States | $0.493B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.490B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.429B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.411B | 22.23 |
| Delcath Systems (DCTH) | United States | $0.403B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.365B | 0.00 |
| NeuroPace (NPCE) | United States | $0.346B | 0.00 |
| CVRx (CVRX) | United States | $0.330B | 0.00 |
| Inogen (INGN) | United States | $0.219B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.199B | 0.00 |
| Accuray (ARAY) | United States | $0.196B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.182B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.178B | 0.00 |
| Nevro (NVRO) | United States | $0.139B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.116B | 12.46 |
| LENSAR (LNSR) | United States | $0.101B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.099B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.089B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.082B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.082B | 0.00 |
| 908 Devices (MASS) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Neuronetics (STIM) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| NexGel (NXGL) | United States | $0.026B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.024B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |